Trial Profile
A prospective study of ferumoxytol-enhanced magnetic resonance angiography (Fe-MRA) for peripheral arterial disease patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Peripheral arterial disorders
- Focus Diagnostic use
- 25 Sep 2015 New trial record